Β-LGND2

β-LGND2, also known as ERβ-selective ligand 2 or as GTx-878, is a synthetic nonsteroidal estrogen and selective ERβ agonist which was under development by GTx for the treatment of benign prostatic hyperplasia, prostatitis, and rheumatoid…

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

β-LGND2, also known as ERβ-selective ligand 2 or as GTx-878, is a synthetic nonsteroidal estrogen and selective ERβ agonist which was under development by GTx for the treatment of benign prostatic hyperplasia, prostatitis, and rheumatoid arthritis but was never marketed. It shows approximately 25-fold selectivity for activation of the ERβ over the ERα ( = 2 nM and 52 nM, respectively). β-LGND2 is an isoquinolinone derivative.

β-LGND2, also known as ERβ-selective ligand 2 or as GTx-878, is a synthetic nonsteroidal estrogen and selective ERβ agonist which was under development by GTx for the treatment of benign prostatic hyperplasia, prostatitis, and rheumatoid arthritis but was never marketed. It shows approximately 25-fold selectivity for activation of the ERβ over the ERα ( = 2 nM and 52 nM, respectively). β-LGND2 is an isoquinolinone derivative.

GTx-878 - AdisInsight

Text derived from https://en.wikipedia.org/w/index.php?oldid=1353197041 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001353197041 · captured 2026-05-08 · not yet sealed in the ledger · verify the chain · version history

Cite this page as: encyclopegia.org, “Β-LGND2”, snapshot enwiki-001353197041. https://encyclopegia.org/a/lgnd2

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.